Moderna Inc. gained US approval for a new Covid vaccine for a narrower group of people, in the latest sign that regulators ...

Moderna (MRNA) stock in focus as the U.S. FDA approved its next-gen COVID-19 vaccine, mNEXSPIKE,. Read more here.

The FDA approved Novavax’s COVID vaccine Nuvaxovid this month, limiting its use to older adults and people over the age of 12 with conditions that put them at risk due to the illness.

NEXSPIKE becomes Moderna’s third FDA-approved product CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc.

The FDA said on May 20 it planned to require drugmakers to test their Covid booster shots against an inert placebo in healthy ...

The U.S. Food and Drug Administration has approved Moderna's next-generation COVID-19 vaccine for everyone aged 65 and above, ...

RFK Jr. announced this week that the federal government is removing the recommendation that kids and pregnant women get ...

The Centers for Disease Control and Prevention says children without underlying health conditions "may receive" a COVID-19 ...

The Department of Health and Human Services (HHS) has canceled funding pledged to Moderna for the development of mRNA-based ...

The U.S. Centers for Disease Control and Prevention is still recommending COVID-19 vaccines for healthy children, according ...

That kind of recommendation, known as shared decision-making, still means health insurers must pay for the vaccinations, ...

Pharmaceutical rivals don’t often come to each other’s defense. But after the US Department of Health and Human Services ...